The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei
Abstract
Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses. Ivermectin resistance has been documented for some intestinal helminths in animals with intensive ivermectin exposure. Ivermectin resistance has also been induced in arthropods in laboratory experiments but, to date, has not been documented among arthropods in nature. We report clinical and in vitro evidence of ivermectin resistance in 2 patients with multiple recurrences of crusted scabies who had previously received 30 and 58 doses of ivermectin over 4 and 4.5 years, respectively. As predicted, ivermectin resistance in scabies mites can develop after intensive ivermectin use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K., & Cowman, A. F. (2000) · Nature · doi:10.1038/35002615 · Cited by 866
Chosidow, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)09458-1 · Cited by 483
Parish, L. C., & Witkowski, J. A. (1989) · Sexually Transmitted Diseases · doi:10.1007/978-1-4612-3528-6_12 · Cited by 321
The Treatment of Scabies with Ivermectin
Meinking, T. L., Taplin, D., Herminda, J. L., Pardo, R., & Kerdel, F. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330105 · Cited by 298
Xu, M., Molento, M., Blackhall, W., Ribeiro, P., Beech, R., & Prichard, R. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00215-6 · Cited by 294
Genetic variability following selection of Haemonchus contortus with anthelmintics
Prichard, R. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)01983-3 · Cited by 289
A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies☆, ☆☆
USHA, V, & GOPALAKRISHNANNAIR, T. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90131-2 · Cited by 244
THE TREATMENT OF SCABIES WITH IVERMECTIN.
&NA; (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199602000-00032 · Cited by 243
Skin infections and infestations in Aboriginal communities in northern Australia
Currie, B. J., & Carapetis, J. R. (2000) · Australasian Journal of Dermatology · doi:10.1046/j.1440-0960.2000.00417.x · Cited by 233
Self-citationKane, N. S., Hirschberg, B., Qian, S., Hunt, D., Thomas, B., Brochu, R., Ludmerer, S. W., Zheng, Y., Smith, M., Arena, J. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240464697 · Cited by 198
Cited by
Chosidow, O. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp052784 · Cited by 452
Moxidectin and the avermectins: Consanguinity but not identity
Prichard, R., Ménez, C., & Lespine, A. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.04.001 · Cited by 439
Prevalence of scabies and impetigo worldwide: a systematic review
Romani, L., Steer, A. C., Whitfeld, M. J., & Kaldor, J. M. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00132-2 · Cited by 435
Problems in Diagnosing Scabies, a Global Disease in Human and Animal Populations
Walton, S. F., & Currie, B. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-06 · Cited by 423
Self-citationScabies: a ubiquitous neglected skin disease
Hengge, U. R., Currie, B. J., Jäger, G., Lupi, O., & Schwartz, R. A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70654-5 · Cited by 403
Self-citationScabies in the developing world–-its prevalence, complications, and management
Hay, R. J., Steer, A. C., Engelman, D., & Walton, S. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03798.x · Cited by 386
Self-citationEuropean guideline for the management of scabies
Salavastru, C. M., Chosidow, O., Boffa, M. J., Janier, M., & Tiplica, G. S. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14351 · Cited by 347
Heukelbach, J., & Feldmeier, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68772-2 · Cited by 338
Permethrin and ivermectin for scabies.
Currie, B. J., & McCarthy, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmct0910329 · Cited by 319
Self-citationMass drug administration for scabies control in a population with endemic disease.
Romani, L., Whitfeld, M. J., Koroivueta, J., Kama, M., Wand, H., Tikoduadua, L., Tuicakau, M., Koroi, A., Andrews, R., Kaldor, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500987 · Cited by 268
Scabies: more than just an irritation
McCarthy, J. S., Kemp, D. J., Walton, S. F., & Currie, B. J. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.014563 · Cited by 256
Self-citationThe public health control of scabies: priorities for research and action.
Engelman, D., Cantey, P. T., Marks, M., Solomon, A. W., Chang, A. Y., Chosidow, O., Enbiale, W., Engels, D., Hay, R. J., Hendrickx, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31136-5 · Cited by 223
Scabies in healthcare settings.
Bouvresse, S., & Chosidow, O. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328336821b · Cited by 96
Metadata
- Authors
- Currie, B. J., Harumal, P., McKinnon, M., & Walton, S. F.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-01
- Volume
- 39
- Issue
- 1
- Pages
- e8-e12
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2109097527
- Cited by
- 317
- References
- 23
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.